Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Zalicus Inc. (ZLCS)

-NasdaqCM
1.21 Down 0.14(10.37%) 3:59PM EDT
Get the big picture on all your investments.
Prev Close:1.35
Open:1.27
Bid:1.18 x 100
Ask:1.21 x 5500
1y Target Est:1.20
Beta:2.05
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.18 - 1.38
52wk Range:0.88 - 8.28
Volume:2,531,282
Avg Vol (3m):937,029
Market Cap:31.48M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZLCS

Comparison

Symbol% ChgMkt Cap
ZLCSDown 10.37%31.48M
ACTDown 1.00%34.39B
NVSUp 0.31%205.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Mar-14) :0.20
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatm... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback